σ Receptors: potential medications development target for anti-cocaine agents
- 1 May 2003
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 469 (1-3), 1-12
- https://doi.org/10.1016/s0014-2999(03)01723-0
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- The analgesic tropane analogue (±)-SM 21 has a high affinity for σ2 receptorsLife Sciences, 1999
- ATM: from gene to functionHuman Molecular Genetics, 1998
- Cloning and Structural Analysis of the cDNA and the Gene Encoding the Murine Type 1 Sigma ReceptorBiochemical and Biophysical Research Communications, 1997
- Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol estersOncogene, 1997
- Cloning and Functional Expression of the Human Type 1 Sigma Receptor (hSigmaR1)Biochemical and Biophysical Research Communications, 1996
- Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labelingEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Sigma receptors are associated with cortical limbic areas in the primate brainSynapse, 1992
- Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative studyBrain Research, 1992
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- Endogenous ligands for sigma opioid receptors in the brain (“sigmaphin”): Evidence from binding assaysLife Sciences, 1986